As of Sep 13
| -0.23 / -0.23%|
The 12 analysts offering 12-month price forecasts for Celgene Corp have a median target of 100.00, with a high estimate of 104.00 and a low estimate of 90.00. The median estimate represents a +1.63% increase from the last price of 98.40.
The current consensus among 18 polled investment analysts is to Hold stock in Celgene Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.